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Staphylococcus aureus and Escherichia coli are among the most prevalent species of gram-positive and
gram-negative bacteria, respectively, that induce clinical mastitis. The innate immune system comprises the
immediate host defense mechanisms to protect against infection and contributes to the initial detection of and
proinflammatory response to infectious pathogens. The objective of the present study was to characterize the
different innate immune responses to experimental intramammary infection with E. coli and S. aureus during
clinical mastitis. The cytokine response and changes in the levels of soluble CD14 (sCD14) and lipopolysac-
charide-binding protein (LBP), two proteins that contribute to host recognition of bacterial cell wall products,
were studied. Intramammary infection with either E. coli or S. aureus elicited systemic changes, including
decreased milk output, a febrile response, and induction of the acute-phase synthesis of LBP. Infection with
either bacterium resulted in increased levels of interleukin 1 (IL-1), gamma interferon, IL-12, sCD14, and
LBP in milk. High levels of the complement cleavage product C5a and the anti-inflammatory cytokine IL-10
were detected at several time points following E. coli infection, whereas S. aureus infection elicited a slight but
detectable increase in these mediators at a single time point. Increases in IL-8 and tumor necrosis factor alpha
were observed only in quarters infected with E. coli. Together, these data demonstrate the variability of the host
innate immune response to E. coli and S. aureus and suggest that the limited cytokine response to S. aureus may
contribute to the well-known ability of the bacterium to establish chronic intramammary infection.
Mastitis is an inflammation of the mammary gland that often
develops in response to intramammary bacterial infection (51).
Mastitis is an important public health problem in humans in
developing countries, as well as in domesticated animals used
in agriculture worldwide. In humans, mastitis is associated with
increased mother-to-child transmission of human immunode-
ficiency virus (27) and bacterial pathogens (8, 46). Further, the
inflammatory mediators produced during the host response to
intramammary infection have been implicated in infant gut
damage (54, 70). In addition to its implications in the patho-
genesis of disease in humans, mastitis remains one of the most
costly diseases in animal agriculture, with economic losses to
the dairy industry approaching $2 billion annually in the
United States alone (37).
Staphylococcus aureus and Escherichia coli account for the
majority of clinical mastitis cases in cattle (7), whereas, S.
aureus is the most prevalent pathogen associated with human
mastitis (4). Striking differences exist between the courses of
bovine intramammary infection caused by S. aureus and E. coli.
Intramammary infection by E. coli is acute in nature and gen-
erally clears within a few days (57). In contrast, infection by S.
aureus is often less severe but results in a chronic infection that
can persist for the life of the animal (60).
The innate immune system represents the first line of de-
fense in the host response to infection and is poised to imme-
diately recognize and respond to the earliest stages of infection
(24). Further, the innate immune system is able to respond to
pathogens that have not been previously encountered. The
inherent capability of the innate immune system to respond to
a vast number of pathogens is mediated by its ability to recog-
nize highly conserved motifs shared by diverse pathogens.
These motifs, commonly referred to as pathogen-associated
molecular patterns (PAMPs), include the bacterial cell wall
components, lipopolysaccharide (LPS), peptidoglycan (PGN),
and lipoteichoic acid (LTA) (1). The ability to recognize com-
mon PAMPs on distinct pathogens (e.g., the presence of LPS
on all gram-negative bacteria) enables the innate immune sys-
tem to respond to vast numbers of infectious agents with only
a limited repertoire of host recognition elements.
Innate recognition of PAMPs is mediated by evolutionarily
conserved pattern recognition receptors (PRRs) (1). Toll-like
receptors (TLRs) comprise a family of PRRs that are capable
of recognizing distinct PAMPs. At least 10 members of the
TLR family have been identified in mammals, and each mem-
ber is capable of recognizing a distinct PAMP (66). For exam-
ple, TLR-2 recognizes PGN (72) and LTA (35, 52) from S.
aureus and other gram-positive bacteria, whereas, TLR-4 rec-
ognizes LPS from gram-negative bacteria, including E. coli
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(22). PGN and LPS activations of distinct TLRs elicit different
in vitro cellular responses (2, 38, 44). Further, differential ac-
tivation of TLRs by whole gram-positive or gram-negative bac-
teria evokes distinct gene expression profiles in vitro (38).
A key component of the host innate immune response to
infection is the upregulation of cytokine production (15, 28,
59). Two well-described proinflammatory cytokines, tumor ne-
crosis factor alpha (TNF-) and interleukin 1 (IL-1), medi-
ate the inflammatory response at both the local and systemic
levels (15, 62). Locally, these cytokines induce vascular endo-
thelial adhesion molecule expression, thereby promoting neu-
trophil transendothelial migration to the site of infection. Sys-
temically, TNF- and IL-1 are potent inducers of fever and
the acute-phase response. Induction of the acute-phase re-
sponse results in increased hepatic synthesis of proteins, such
as LPS-binding protein (LBP) and C-reactive protein, which
facilitate host detection of bacterial-wall products and comple-
ment activation, respectively (67). Neutrophil recruitment to
the site of infection is further mediated by the upregulation of
the chemoattractant IL-8 (20). IL-12 contributes to the innate
immune response by stimulating the production of gamma
interferon (IFN-), an activator of neutrophils and macro-
phages (64). Finally, resolution of the inflammatory process is
mediated by the upregulation of IL-10, which downregulates
proinflammatory cytokine production (45, 58).
Since establishment of infection is governed, in part, by the
nature of the host response to the invading organism and E.
coli and S. aureus are known to follow distinct clinical courses
during intramammary infection, the present study examined
the differential in vivo cytokine response elicited in the mam-
mary gland during infection with either S. aureus or E. coli. In
addition, we studied changes in the intramammary concentra-
tions of LBP and soluble CD14 (sCD14), two accessory mol-
ecules that contribute to host innate recognition of compo-
nents of the bacterial cell wall.
MATERIALS AND METHODS
Cows. Sixteen healthy midlactating Holstein cows (214  8.67 days in milk)
were selected on the basis of milk somatic cell counts (SCC) of 500,000/ml and
the absence of detectable bacterial growth from three daily consecutive asepti-
cally collected milk samples plated on blood agar plates. The use and care of all
animals in this study were approved by the Beltsville Agricultural Research
Center’s Animal Care and Use Committee.
Intramammary challenge with E. coli or S. aureus. Prior to intramammary
challenge, 10 ml of brain heart infusion broth (Becton Dickinson Diagnostic
Systems, Inc., Sparks, Md.) was inoculated with either E. coli strain P4 (a gift of
A. J. Bramley, Institute for Animal Health, Compton Laboratory, Newbury,
England) or S. aureus strain 305 (American Type Culture Collection, Manassas,
Va.) and incubated for 6 h at 37°C. These strains were originally isolated from
clinical cases of mastitis and have been used as model organisms in other studies
of mastitis (9, 40). One milliliter of the incubated cultures was transferred to
aerating flasks containing 99 ml of tryptic soy broth and incubated overnight at
37°C. After incubation, the flasks were placed in an ice water bath and mixed by
swirling. A 1-ml aliquot from each flask was serially diluted in PBS, and 1 ml of
the resulting dilutions was mixed with 9 ml of premelted trypticase soy agar in
petri dishes. The plates were allowed to solidify at room temperature and then
were transferred to a 37°C incubator overnight. The aerating flasks containing
the stock cultures were maintained at 4°C overnight. After the concentration of
the stock culture was determined based on the prepared pour plates, the stock
culture was diluted in phosphate-buffered saline (PBS) to yield a final concen-
tration of 40 CFU/ml.
Immediately following the morning milking, one front or rear quarter of each
of 16 cows was infused with either E. coli (n  8) or S. aureus (n  8). The
contralateral quarter of each infected quarter was infused with 2 ml of PBS. Pour
plating of the final prepared inoculum confirmed that the cows received 72 or 74
CFU of E. coli or S. aureus/quarter, respectively. Following challenge, aseptic
milk samples were collected from all quarters at various times, serially diluted,
and plated on blood agar plates. Following a 16-h incubation at 37°C, the
numbers of CFU per milliliter were determined. Colonies composed of gram-
positive cocci that were both catalase and coagulase positive were initially
counted as S. aureus. Those colonies that displayed characteristics similar to
those of E. coli and that were confirmed to be gram-negative, oxidase-negative
rods were initially counted as E. coli. Further biochemical tests and gas chroma-
tography were performed by the Animal Health Section, Maryland Department
of Agriculture (College Park, Md.), to confirm the initial identification.
Determination of milk SCC and circulating-neutrophil counts. To quantitate
somatic cells, milk samples were heated to 60°C and subsequently maintained at
40°C until the cells were counted on an automated cell counter (Fossomatic
model 90; Foss Food Technology, Hillerod, Denmark) as previously described
(34). For the determination of circulating-neutrophil counts, tail vein blood
samples were collected in Vacutainer glass tubes containing K3 EDTA (Becton
Dickinson Corp., Franklin Lakes, N.J.), inverted 10 times, placed on a rocker for
15 min, and analyzed using a HEMAVET 3700 automated multispecies hema-
tology system (CDC Technologies, Inc., Oxford, Conn.).
Whey and plasma preparation. For the preparation of whey, milk samples
were centrifuged at 44,000	 g and 4°C for 30 min, and the fat layer was removed
with a spatula. The skim milk was decanted into a clean tube and centrifuged
again for 30 min as described above, and the translucent supernatant was col-
lected and stored at 
70°C. For the preparation of plasma, tail vein blood
samples were collected as described above, inverted 10 times, and centrifuged at
1,500 	 g for 15 min, and the clear plasma supernatant was collected, aliquoted,
and stored at 
70°C.
ELISAs for BSA, IL-8, IFN-, sCD14, and LBP. Enzyme-linked immunosor-
bent assays (ELISAs) for bovine serum albumin (BSA), IL-8, sCD14, and LBP
were performed as previously described (6). A commercially available kit (Bio-
source International, Inc., Camarillo, Calif.) was used to measure bovine IFN-
in undiluted whey samples according to the manufacturer’s instructions. Recom-
binant bovine IFN- (Serotec, Inc., Raleigh, N.C.) was used to generate a
standard curve for the ELISA.
ELISAs for TNF- and IL-1. Flat-bottom 96-well plates (Nalge Nunc Inter-
national, Rochester, N.Y.) were coated overnight at 4°C with 100 l of 0.05 M
sodium carbonate, pH 9.6, containing either mouse anti-recombinant bovine
TNF- (diluted 1:1,000) (41) or mouse anti-ovine IL-1 (5 g/ml) antibody
(Serotec, Inc.). The plates were washed four times with 0.05% Tween 20 diluted
in 50 mM Tris-buffered saline (TBS), pH 8.0, and subsequently blocked with 2%
fish skin gelatin (Sigma Chemical Co., St. Louis, Mo.) for 1 h at room temper-
ature. The plates were washed, and 100 l of diluted whey samples (1:5 and 1:1,
respectively, for the anti-TNF-- and anti-IL-1-coated plates) was added to
each well. Standard curves of known amounts of either recombinant bovine
TNF- (Genentech Corp., South San Francisco, Calif.) or recombinant ovine
IL-1 (a gift from CSIRO Livestock Industries, Victoria, Australia) were assayed
in parallel. The plates were incubated for 1.5 h at room temperature and sub-
sequently washed as described above. Rabbit anti-recombinant bovine TNF-
polyclonal serum (41) or rabbit anti-recombinant ovine IL-1 polyclonal serum
(Serotec) was diluted 1:5,000 or 1:500, respectively, in TBS wash buffer contain-
ing 2% gelatin, and 100 l was added to each well. The plates were incubated for
1 h at room temperature and washed. Goat anti-rabbit immunoglobulin G (IgG)
conjugated to horseradish peroxidase (HRP) (Becton Dickinson Corp.) was
diluted 1:5,000 (TNF- plates) or 1:10,000 (IL-1 plates) in TBS wash buffer
containing 2% gelatin, and 100 l was added to each well of the respective plates.
Following a 1-h incubation, the plates were washed, and 100 l of 3,3,5,5-
tetramethylbenzidine (TMB) substrate solution (Kirkegaard and Perry Labora-
tories Inc., Gaithersburg, Md.) was added to each well. The reaction was stopped
by the addition of 100 l of 2 M H2SO4, and the absorbance was read at 450 nm
on a microplate reader (Bio-Tec Instruments, Inc., Winooski, Vt.). A back-
ground correction reading at 565 nm was subtracted from the 450-nm absorbance
readings.
ELISA for IL-10 and IL-12. Concentrations of IL-10 and IL-12 were deter-
mined as previously described with slight modification (25, 29). Briefly, flat-
bottom 96-well plates were coated overnight at 4°C with 4 g of mouse anti-
bovine IL-10 (CC-318) or IL-12 (CC-301) antibody/ml diluted in 0.05 M sodium
carbonate, pH 9.6. The plates were washed four times with 0.05% Tween 20
diluted in 50 mM TBS, pH 8.0, and subsequently blocked with 2% fish skin
gelatin for 1 h at room temperature. The plates were washed, and 100 l of
diluted (1:5) or undiluted whey samples was added to the anti-IL-10- or anti-IL-
12-coated plates, respectively. Following a 1-h incubation at room temperature,
the plates were washed, and 100 l of either biotin-conjugated mouse anti-bovine
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IL-10 (CC-320) or IL-12 (CC-326) antibody diluted to 1 or 8 g/ml, respectively,
was added to the wells of the respective plates. The plates were incubated for 1 h
at room temperature and washed. HRP-conjugated streptavidin (Sigma Chem-
ical Co.) was diluted 1:500 in TBS wash buffer containing 2% gelatin, and 100 l
of this solution was added to each well. The plates were incubated for 1 h at room
temperature and washed, and TMB substrate solution as added to each well. The
reaction was stopped by the addition of 100 l of 2 M H2SO4, and the absorbance
was read at 450 nm on a microplate reader. A background correction reading at
565 nm was subtracted from the 450-nm absorbance readings. Supernatants
derived from COS-7 cells transfected with either IL-10- or IL-12-encoding plas-
mids and previously assayed for biological activity were used to generate a
standard curve for each ELISA (25, 29). The concentration of IL-10 or IL-12 in
milk was calculated by extrapolating from the respective standard curves, and the
values were expressed as biological units of activity per milliliter.
ELISA for C5a. Concentrations of complement cleavage factor 5a (C5a) in
milk were measured by sandwich ELISA using anti-bovine C5a monoclonal
antibody for antigen capture and rabbit anti-bovine C5a antiserum for detection
(43). Flat-bottom 96-well plates were coated overnight at 4°C with goat anti-
mouse IgG (Jackson Immunoresearch Laboratories, Inc., West Grove, Pa.) di-
luted to 5 g/ml in 0.05 M sodium carbonate, pH 9.6. The plates were washed five
times with 0.05% Tween 20 diluted in 50 mM TBS, pH 8.0, and subsequently
blocked with 0.5% fish skin gelatin for 30 min at 37°C. The plates were washed,
and 100 l of anti-C5a monoclonal antibody/well diluted 1:5,000 in 0.05% Tween
20–TBS containing 0.1% gelatin was added to each well. Following a 1-h incu-
bation at 37°C, the plates were washed, and 100 l of whey diluted 1:10 in 0.05%
Tween 20–TBS containing 0.1% gelatin and 1 mM EDTA was added to each
well. The plates were incubated for 1.5 h at room temperature and washed, and
100 l of rabbit anti-bovine C5a/C5 diluted 1:2,500 in 0.05% Tween 20–TBS
containing 0.1% gelatin was added to each well. The plates were incubated for 30
min at 37°C and washed, and 100 l of goat anti-rabbit IgG conjugated to HRP
(1:5,000 dilution in 0.05% Tween 20–TBS containing 0.1% gelatin) was added to
each well. Following a 30-min incubation at 37°C, the plates were washed, and
100 l of TMB substrate solution was added to each well. The reaction was
stopped by the addition of 100 l of 2 M H2SO4, and the absorbance was read
at 450 nm on a microplate reader. A background correction reading at 565 nm
was subtracted from the 450-nm absorbance readings. Values expressed in nano-
grams per milliliter were calculated from a standard curve of known amounts of
purified C5a.
Statistical methods. Repeated-measures analysis of variance with the Dunnett
post hoc comparison test was performed using the PROC MIXED model (SAS
version 8.2; SAS Institute, Cary, N.C.) to compare the mean responses of the
experimental groups and the preinfused (time zero) groups. For statistical anal-
ysis of milk SCC, data were transformed to log10 values. An unpaired t test
(Prism version 4.0 for Windows; GraphPad Software Inc., San Diego, Calif.) was
used to compare the maximal responses elicited by S. aureus and E. coli in a given
experimental assay. A P value of 0.05 was considered significant.
RESULTS
Bacterial growth in infected quarters. Within 16 h of chal-
lenge, viable bacteria were recovered from all eight quarters
challenged with S. aureus (Fig. 1A). Transient decreases in the
number of quarters from which viable S. aureus organisms
were recovered occurred at 48 and 96 h postinfection and may
reflect the cyclical shedding of S. aureus into milk that has been
described (13). In those eight quarters infused with E. coli,
viable bacteria were recovered at least once from each infected
quarter within 32 h of challenge; however, at no single time
point were bacteria recovered from all eight quarters. The
viable bacteria recovered from the S. aureus- and E. coli-in-
fused quarters were all confirmed to be the same species of
bacteria infused at time zero. Saline-infused quarters remained
free of detectable pathogens throughout the study. Within 8 h
of challenge, comparable numbers of E. coli (3.36  0.18 log10
CFU/ml) and S. aureus (3.34  0.48 log10 CFU/ml) were re-
covered from infected glands (Fig. 1B). At later time points,
however, consistently higher numbers of CFU were recovered
from S. aureus-infected quarters than from those infected with
E. coli. By the final day of the study, E. coli was recovered from
only a single quarter, whereas S. aureus was recovered from six
of the eight initially infected quarters (Fig. 1A).
Systemic response to intramammary challenge with either
E. coli or S. aureus. Daily milk weights for cows infected with
either E. coli or S. aureus dropped by 42 and 21%, respec-
tively, on the day following challenge (Fig. 2A). The mean milk
output of E. coli-infected cows (16.62  2.23 kg) was signifi-
cantly lower than that of cows infected with S. aureus (22.44 
2.14 kg) on the first day after challenge (P  0.041). Milk
output remained significantly depressed for 2 days following E.
coli or S. aureus challenge. Elevated rectal temperatures were
detected at 16 and 32 h postinfection with E. coli or S. aureus,
respectively (Fig. 2B). Peak elevations in body temperature
were higher in cows receiving E. coli (40.5  0.45°C) than in
those infused with S. aureus (39.3  0.15°C) (P  0.024).
Intramammary infection with either E. coli or S. aureus
induces an increase in milk SCC with or without, respectively,
a corresponding decrease in circulating neutrophils. A de-
crease in the number of circulating neutrophils was evident
within 16 h of E. coli challenge and reached a minimum of
1,963 562 cells/l (Fig. 3A). In contrast, significant decreases
in circulating neutrophils in cows challenged with S. aureus
were not observed until 120 h after infection. Increases in milk
somatic cells, which are primarily composed of neutrophils
during the acute phase of infection (50), were evident within 16
and 24 h of E. coli or S. aureus challenge, respectively (Fig. 3B).
Milk SCC peaked within 40 h of infection in quarters chal-
lenged with either bacterium. There was no significant differ-
FIG. 1. Intramammary growth of E. coli and S. aureus following
experimental challenge. Following intramammary infusion of eight
quarters with 72 CFU of E. coli or eight quarters with 74 CFU of S.
aureus, sterile milk samples were collected from all infused quarters at
various times and plated. (A) Number of quarters in which viable
bacteria were recovered. (B) Means ( standard error) of log10 CFU
per milliliter in those quarters where bacteria were recovered.
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ence (P  0.12) between the maximal milk SCC reached in
quarters infected with E. coli (44.9	 106 5.04	 106 cells/ml)
and in those infected with S. aureus (32.1 	 106  5.9 	 106
cells/ml). Milk SCC in all infected quarters remained elevated
relative to prechallenge levels throughout the study.
Intramammary infection with E. coli or S. aureus elicits an
increase in mammary vascular permeability. Quarters infused
with either E. coli or S. aureus demonstrated increases in levels
of BSA in milk, which reflected increases in mammary vascular
permeability (Fig. 4). Initial increases in BSA levels in E.
coli-infused quarters preceded by 16 h those increases ob-
served in quarters inoculated with S. aureus. The maximal
increases in BSA levels were comparable in quarters infected
with either bacterium. Within 48 to 72 h of infection, milk BSA
levels in all infected quarters returned to prechallenge levels.
Differential changes in levels of IL-8 and C5a following
intramammary challenge with either E. coli or S. aureus. In-
tramammary infection with E. coli induced an increase in con-
centrations of the chemoattractants IL-8 and C5a in milk
within 16 h of challenge (Fig. 5). The elevated levels of IL-8
and C5a in milk persisted through 24 and 48 h, respectively,
following challenge. S. aureus elicited a transient increase in
C5a concentrations in milk at 32 h postinfection (Fig. 5B) but
failed to induce IL-8 production (Fig. 5A). The increase in C5a
in S. aureus-infected quarters varied considerably among cows,
and two of the eight infected quarters showed no measurable
increases. Increases in C5a were detected in all quarters chal-
lenged with E. coli. The mean peak concentrations of C5a
following E. coli infection (27.29  7.29 ng/ml) approached,
FIG. 2. Effects of intramammary infection with E. coli or S. aureus
on daily milk weights and temperatures. (A) Total milk weight (sum of
morning and evening outputs) data were collected 1 day prior to
infection (
1), the day of infection (0), and for 5 days following
infection. The vertical bars represent the means (plus standard error)
of milk weights.  and #, significantly decreased compared to prechal-
lenge levels (day 
1) in cows challenged with E. coli or S. aureus,
respectively (P  0.05). (B) Rectal temperatures were measured im-
mediately prior to and at various times following intramammary infec-
tion as an indicator of the systemic response. Mean ( standard error)
temperatures are shown.  and #, significantly increased compared to
time zero in cows challenged with E. coli or S. aureus, respectively (P
 0.05).
FIG. 3. Effects of intramammary infection with E. coli or S. aureus
on circulating neutrophils and milk SCC. (A) Total differential neu-
trophil counts were determined in blood samples collected immedi-
ately prior to and at various times following intramammary infection.
Mean ( standard error) cell counts are shown.  and #, significantly
decreased compared to time zero in cows challenged with E. coli or S.
aureus, respectively (P  0.05). (B) Milk SCC were quantified in milk
samples collected from both infected and PBS-infused quarters
throughout the study. Mean ( standard error) milk SCC are shown.
 and #, significantly increased in E. coli- or S. aureus-infected quar-
ters, respectively, relative to time zero (P  0.05).
FIG. 4. Intramammary infection with E. coli or S. aureus increases
concentrations of BSA in milk. As a marker of mammary vascular
permeability, BSA levels were assayed by ELISA in milk samples
obtained from quarters immediately prior to and at various times
following intramammary infusion with saline, E. coli, or S. aureus.
Mean ( standard error) BSA levels are shown.  and #, significantly
increased in E. coli- or S. aureus-infected quarters, respectively, rela-
tive to time zero (P  0.05).
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but did not reach, levels that were significantly different from
those in S. aureus-infected quarters (11.59  5.79 ng/ml) (P 
0.057).
Differential induction of TNF- and IL-1 following intra-
mammary challenge with either E. coli or S. aureus. E. coli and
S. aureus infections both induced increases in mammary IL-1
levels, but only E. coli elicited the production of TNF- (Fig.
6). Initial increases in TNF- levels in the milk from E. coli-
infected quarters were evident within 16 h and persisted
through 32 h postchallenge (Fig. 6A). Increases in IL-1 pro-
duction were highly variable following E. coli challenge and
were significantly increased relative to prechallenge levels only
at 40 h postinfection. Increases in IL-1 levels were evident in
S. aureus-infected quarters 32 h after challenge and persisted
for an additional 8 h (Fig. 6B). Maximal concentrations of
IL-1 were comparable following infection with either bacte-
rium.
Intramammary infection with E. coli or S. aureus induces
production of IL-12, IFN-, and IL-10. Increased levels of
IL-12 in milk were detectable within 24 h of E. coli infection
and peaked 8 h later (Fig. 7A). Initial increases in milk IL-12
concentrations following S. aureus infection occurred 32 h after
challenge. Peak levels of IL-12 were comparable in quarters
infected with either E. coli or S. aureus. Similar to IL-12,
infection with either bacterium elicited comparable production
of IFN-; however, initial increases in E. coli-challenged quar-
ters preceded those in S. aureus-infused quarters by 8 h (Fig.
7B). The increased milk IFN- levels remained elevated in S.
aureus-infected quarters throughout the study, whereas those
in quarters infected with E. coli returned to baseline by 120 h.
Initial increases in IL-10, an anti-inflammatory cytokine,
were observed in milk within 24 h of E. coli infection and
returned to prechallenge levels 16 h later (Fig. 7C). A slight,
but significant, transient increase in milk IL-10 levels was ob-
served in quarters challenged with S. aureus 32 h after infec-
tion. Peak levels of IL-10 in E. coli-challenged quarters (170.1
 57.7 biological units/ml) were significantly higher than those
detected in quarters challenged with S. aureus (13.7  4.9
biological units/ml) (P  0.009).
E. coli and S. aureus intramammary infection augments lev-
els of both sCD14 and LBP in milk. To determine whether
intramammary infection with either bacterium could alter
mammary gland sCD14 and LBP levels, two proteins involved
in host cell recognition of bacterial-wall products, the levels of
these molecules in milk were quantified by ELISA (Fig. 8A
and B). Relative to prechallenged quarters, increased levels of
both sCD14 and LBP were detected within 24 h of E. coli
infection. Peak levels of both molecules were observed 40 h
after infection. Increases in concentrations of LBP and sCD14
in milk were observed in S. aureus-infused quarters within 32
FIG. 5. Effects of intramammary infection with E. coli or S. aureus
on concentrations of IL-8 and C5a in milk. Levels of IL-8 (A) and C5a
(B) in milk following intramammary bacterial or saline challenge were
determined by ELISA. Mean ( standard error) IL-8 and C5a con-
centrations are shown.  and #, significantly increased in E. coli- or S.
aureus-infected quarters, respectively, relative to time zero (P  0.05).
FIG. 6. Effects of E. coli and S. aureus infection on levels of TNF-
and IL-1 in milk. An ELISA was used to measure the concentrations
of TNF- (A) and IL-1 (B) in milk obtained from quarters infused
with saline, E. coli, or S. aureus. Mean ( standard error) TNF- and
IL-1 concentrations are shown.  and #, significantly increased in E.
coli- or S. aureus-infected quarters, respectively, relative to time zero
(P  0.05).
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and 40 h, respectively, of challenge. Similar to E. coli-chal-
lenged glands, peak levels of both molecules were observed
40 h following infection. sCD14, but not LBP, reached a max-
imal concentration in E. coli-infected quarters (28.74  7.24
g/ml) that was significantly higher than that in quarters chal-
lenged with S. aureus (13.89  3.17 g/ml) (P  0.041).
Systemic levels of LBP, a liver-derived protein whose expres-
sion is increased during the acute-phase response to infection,
were also assayed. Circulating blood LBP levels increased
within 24 and 32 h following intramammary infection with E.
coli or S. aureus, respectively, and remained above prechal-
lenge levels until 96 h after infection with either bacterium
(Fig. 8C). Increases in levels of LBP in blood for cows chal-
lenged with either bacterium were temporally coincident with
increases in levels of LBP in milk (Fig. 8B). There were no
significant differences between the peak circulating levels of
LBP in cows challenged with E. coli or S. aureus.
FIG. 7. Intramammary infection with E. coli or S. aureus elicits an
increase in levels of IL-12, IFN-, and IL-10 in milk. ELISAs were
used to measure the levels of IL-12 (A), IFN- (B), and IL-10 (C) in
milk obtained from quarters infused with saline, E. coli, or S. aureus.
Mean ( standard error) IL-12, IL-10, and IFN- concentrations are
shown.  and #, significantly increased in E. coli- or S. aureus-infected
quarters, respectively, relative to time zero (P  0.05).
FIG. 8. Effects of intramammary infection with E. coli or S. aureus
on levels of sCD14 and LBP. Concentrations of sCD14 (A) and LBP
(B) in milk obtained from quarters infused with either saline, E. coli,
or S. aureus, as well as levels of LBP in plasma (C) obtained from these
infected cows, were assayed by ELISA. Mean ( standard error)
concentrations of both proteins are shown.  and #, significantly in-
creased in milk (A and B) or plasma (C) obtained from E. coli- or S.
aureus-infected cows, respectively, relative to time zero (P  0.05).
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DISCUSSION
Intramammary infection with E. coli or S. aureus elicited
both a localized and a systemic response. Systemic signs fol-
lowing infection with either bacterium included decreased milk
output (Fig. 2A), a febrile response (Fig. 2B), and elevated
levels of the acute-phase protein LBP (Fig. 8C). Localized
signs included increased permeability of the mammary vascu-
lature (Fig. 4) and elevated milk SCC (Fig. 3B) in the infected
quarters. Cows infected with E. coli demonstrated an earlier
and more dramatic increase in body temperature, as well as a
more pronounced decrease in milk output.
TNF- and IL-1 are potent inducers of fever and the acute-
phase response (15). In E. coli-challenged quarters, maximal
increases in intramammary TNF- and IL-1 were observed at
16 h postinfection (Fig. 6), a time that was coincident with
increased body temperature (Fig. 2B) and that immediately
preceded increased levels of circulating LBP (Fig. 8C). These
temporal changes in the expression of TNF- and IL-1 in
milk are consistent with a previous study using a different
strain of E. coli (56). In contrast to E. coli-infected quarters,
there was no detectable TNF- production in quarters chal-
lenged with S. aureus, and peak levels of IL-1 were not de-
tected until 32 h postinfection (Fig. 6). This increase in IL-1
correlated with the onset of the febrile response in S. aureus-
infected animals and the induction of the acute-phase synthesis
of LBP. The absence of TNF- production in cows challenged
with S. aureus is consistent with a previous report (48) and may
account for both the delayed and diminished febrile response
and the delayed induction of acute-phase hepatic synthesis
relative to that observed in cows infected with E. coli.
Increases in milk SCC were observed within 16 and 24 h of
infection by E. coli or S. aureus, respectively (Fig. 3B). Saad
and Ostensson have reported that neutrophils constitute
90% of the milk somatic cells present in infected quarters
during the acute stages of mastitis (50). Correspondingly, the
initial increase in milk SCC in E. coli-infected cows paralleled
decreases in circulating neutrophils (Fig. 3A). In contrast, the
delayed initial increase in milk SCC in S. aureus-infected quar-
ters occurred in the absence of detectable decreases in circu-
lating neutrophils. This delay in recruitment of neutrophils to
the mammary gland following S. aureus infection may enable
recruitment from bone marrow stores of white blood cells over
a longer period, thus precluding a decrease in circulating neu-
trophils.
Similar to the findings of Shuster et al. (56), initial neutro-
phil recruitment to quarters infected with E. coli was tempo-
rally coincident with increases in IL-8, C5a, and TNF- in milk,
all of which are chemotactic (Fig. 5 and 6A). Consistent with a
previous report (48), there was no detectable production of
either IL-8 or TNF- in quarters infected with S. aureus; how-
ever, a transient increase in C5a was detected within 32 h of
infection. The increase in C5a occurred at a time when large
increases in milk SCC were observed; however, slight but sig-
nificant initial increases in milk SCC were observed within 24 h
of S. aureus infection. Earlier increases in C5a may have gone
undetected due to sensitivity limitations of the assay. Alterna-
tively, upregulation of other chemoattractants, such as leuko-
triene B4, may have contributed to neutrophil recruitment (23,
49).
Initial increases in milk C5a at 16 and 32 h postinfection with
E. coli or S. aureus, respectively, occurred in parallel with
increased mammary vascular permeability, as evidenced by
elevated milk BSA levels (Fig. 4). Since physiological levels of
milk complement proteins are relatively low (42), these find-
ings suggest a sequence in which serum-derived complement
components leak into the quarter and subsequent activation
results in the generation of detectable levels of complement
fragments.
In comparison to TNF- and IL-8, for which peak levels
were observed 16 h following infection with E. coli, maximal
amounts of IL-12 and IFN- were observed at 32 h (Fig. 7).
Both IL-12 and IFN- levels remained elevated for 40 and
96 h, respectively, postchallenge. Similar changes in the expres-
sion of these cytokines were observed following S. aureus in-
fection; however, the initial increases were detected 8 h later
than those in quarters infected with E. coli. The parallel in-
creases in IL-12 and IFN- in response to infection with either
bacterium are consistent with the ability of each cytokine to
stimulate the production of the other (12, 33, 36). Sustained
and highly elevated increases in IL-10 in milk were observed
following E. coli infection, yet only a slight transient increase
was detected following S. aureus challenge. This is consistent
with a previous study demonstrating that gram-negative bac-
teria are more potent inducers of IL-10 than gram-positive
bacteria (21).
Elevated levels of IL-10 in E. coli-infected quarters were
observed at times in which heightened levels of TNF- de-
clined, consistent with reports that IL-10 inhibits TNF- pro-
duction (5, 11). In contrast, increased levels of IL-12 and
IFN- were temporally coincident with elevated levels of IL-10
in E. coli-challenged quarters, despite reports from studies
using other model organisms and/or in vitro systems that the
latter downregulates the expression of IL-12 and IFN- (14,
61). Interestingly, IFN- levels in S. aureus-infected quarters,
which were virtually devoid of IL-10, remained elevated for a
longer time than those in quarters infected with E. coli, where
IL-10 levels were elevated. Thus, IL-10 may have exerted its
classical downregulatory effect on the expression of IFN- in E.
coli-infected quarters by limiting the duration of expression of
IFN-.
Upregulation of both of the innate immune PRRs, Tlr-2 and
Tlr-4, has recently been reported in cows with mastitis induced
by gram-positive and gram-negative infections (17). LPS acti-
vation of Tlr-4 is dependent on the presence of either mem-
brane-associated CD14 or sCD14 (18, 68). Another protein,
LBP, facilitates LPS interaction with CD14, thus, enhancing
host cell activation by LPS (53, 63). A protective role for CD14
and LBP in mediating host responses to LPS and infection by
gram-negative bacteria has been established using an array of
experimental approaches, including the use of LBP
/
 (16, 26)
or CD14
/
 (71) mice or CD14 neutralizing antibodies (32,
69) and administration of exogenous LBP (30). Recently, it was
demonstrated that coadministration of sCD14 with an inocu-
lum of E. coli enhanced intramammary bacterial clearance,
suggesting a beneficial role for sCD14 in mediating mammary
innate immune responses to infection by gram-negative bacte-
ria (31). In addition to a requisite role in LPS activation of
Tlr-4, CD14 and LBP have been reported to facilitate Tlr-2
activation by LTA and PGN derived from S. aureus and other
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gram-positive bacteria (52, 72). Thus, sCD14 and LBP contrib-
ute to the elicitation of host cell responses to bacterial cell wall
products derived from both gram-positive and gram-negative
bacteria via Tlr-2- and Tlr-4-mediated activation, respectively.
Intramammary challenge with E. coli induced a significant
increase in both sCD14 and LBP concentrations in infected
quarters (Fig. 8). Initial increases in both proteins were ob-
served within 24 h of infection and reached maximal levels 16 h
later. Like E. coli infection, S. aureus infection resulted in
similar increases in sCD14 and LBP, with the levels of both
proteins peaking 40 h following infection. Because LBP and
sCD14 act in concert to facilitate host recognition of bacterial-
wall products, the simultaneous increase in the concentrations
of both of these proteins following infection with either bac-
terium would be expected to be optimally beneficial to the
host. The fact that initial increases in IL-8 and TNF- in E.
coli-infected quarters preceded changes in LBP and sCD14
concentrations suggests that the induction of initial proinflam-
matory responses may occur in the presence of physiological
levels of sCD14 and LBP. Interestingly, peak levels of milk
SCC and of IL-12 and IFN- production were all observed at
times of maximal elevation of both sCD14 and LBP, thereby
raising the possibility that maximal neutrophil recruitment and
elevation of these cytokines are dependent upon augmented
levels of sCD14 and/or LBP. Elevated levels of sCD14 and
LBP at a time of maximal neutrophil recruitment would be
expected to be advantageous to the host, as both of the mol-
ecules enhance neutrophil function (19, 55, 65).
Increased concentrations of LBP in quarters infected with
either bacterium were temporally coincident with elevated
plasma LBP levels (Fig. 8C) and occurred at a time of in-
creased mammary vascular permeability (Fig. 4). This finding
is compatible with leakage of LBP from the vascular compart-
ment into the infected quarters. The assay used to detect
sCD14 in milk was unable to determine sCD14 concentrations
in plasma, presumably due to interference from plasma com-
ponents. This plasma interference effect has been reported in
other ELISAs as well (39). Therefore, whether the increases in
sCD14 were a result of vascular leakage remains unknown. Lee
et al. have suggested that increases in intramammary sCD14
during the course of mastitis may result from CD14 shedding
from the neutrophil surface (31). Consistent with this hypoth-
esis, increases in sCD14 levels (Fig. 8A) paralleled elevations
in milk SCC (Fig. 3B) in quarters infected with either E. coli or
S. aureus. Further, higher levels of sCD14 were found in E.
coli-infected quarters, where there were higher milk SCC than
in quarters challenged with S. aureus.
To our knowledge, the present study is the first to examine
differences in the inflammatory responses during clinical mas-
titis elicited by E. coli and S. aureus. The interpretation of
results from the only other study to examine the intramammary
innate immune responses to these two bacteria was limited by
the different clinical outcomes following infection (48). In that
study, cows infected with E. coli developed clinical mastitis,
whereas those infected with S. aureus developed subclinical
mastitis. Thus, the differences identified in that report could
have been attributed to the differential severity of inflamma-
tion that ensued. In the present study, all of the cows devel-
oped clinical mastitis. Another difference between the previous
and present studies concerns the relative titers of E. coli and S.
aureus recovered from infected glands. The study by Riollet et
al. reported 2-log-unit-higher recovery of bacteria from the
quarters infused with E. coli than from those infected with S.
aureus (48). Thus, the lack of a proinflammatory cytokine re-
sponse elicited in S. aureus-infected quarters in that study
could have been attributed to the lower titers of S. aureus
relative to those of E. coli. In the present report, comparable or
higher numbers of CFU of S. aureus per milliliter than of E.
coli were recovered. Thus, the present study establishes that
the differences between the innate immune responses to these
two bacteria cannot be ascribed to differences in titers. Finally,
the previous report by Riollet et al. examined only a limited
number of cytokines, including IL-1, IL-8, and TNF- (48).
We have now extended those findings by studying several ad-
ditional aspects of the innate immune response, including (i)
differential induction of the cytokines IL-10, IL-12, and IFN-;
(ii) changes in the levels of the innate immune accessory mol-
ecules sCD14 and LBP; (iii) systemic changes reflecting milk
output, febrile response, and induction of the acute-phase re-
sponse; and (iv) changes in milk SCC relative to decreases in
circulating neutrophils.
Consistent with the findings of Riollet et al. (48), we found
that E. coli, but not S. aureus, could elicit production of IL-8
(Fig. 5A) and TNF- (Fig. 6A). In contrast, we observed an
increase in IL-1 in response to infection with either bacterium
(Fig. 6B), whereas the previous study reported increases in
IL-1 only in response to E. coli. Since the strain of S. aureus
used in the present study led to the development of clinical
mastitis whereas that in the previous study elicited subclinical
mastitis, the differential severity of the clinical course may have
influenced the production of IL-1. Alternatively, the discrep-
ancy in findings may be attributed to the high variability asso-
ciated with the assay. A previous study showed an increase in
IL-1 mRNA in milk somatic cells following S. aureus chal-
lenge (47), consistent with our finding of increased levels of
soluble IL-1 as assayed by ELISA.
Interestingly, increases in milk somatic cell TNF- mRNA
have been reported in two studies following S. aureus challenge
(3, 47), yet at the protein level, we and others (48) have been
unable to detect corresponding increases in TNF- by ELISA.
Thus, detectable increases in mRNA levels are not necessarily
indicative of increased secreted levels of protein. In the present
study, we have directly assayed for all cytokines and innate
immune accessory molecules by ELISA. To our knowledge,
this is the first comprehensive report to differentiate E. coli-
and S. aureus-elicited intramammary changes in levels of sol-
uble IL-10, IL-12, IFN-, sCD14, and LBP.
Although the innate immune system has evolved to respond
to the multitude of bacterial species that exist in nature, the
present report clearly establishes that different in vivo re-
sponses are elicited by distinct bacterial pathogens. Because
the ability of bacteria to establish infection is mediated in
part by the ability of the host to respond to the invading
organism (10), the differences reported here between the
host responses to E. coli and S. aureus may contribute to the
limited acute intramammary infection associated with the
former and the more chronic infectious state characteristic
of the latter.
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